All lobbying filings

KELLEY DRYE & WARREN LLP

KELLEY DRYE & WARREN LLP filed a Q4 report for NMAC on January 20, 2026, reporting $40,000 in lobbying income.

Lobbying for NMAC · Non-profit organization promoting equity in Federal public policy related to HIV/AIDS.

All filings by KELLEY DRYE & WARREN LLP · Everything NMAC has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$40,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

S.2587/H.R.5304, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, Provisions related to funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; and expanded access to re-exposure prophylaxis (PrEP) medications and related support; S.2465/H.R.4552, Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2026, Provisions related to funding for the Housing Opportunities for Persons with AIDS Program (HOPWA)

Bills named in this filing 4

S. 2587
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
H.R. 5304
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
S. 2465
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2026
H.R. 4552
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2026

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.